Q4 2021 Aptose Biosciences Inc Earnings Call Transcript

Mar 22, 2022 / 09:00PM GMT
Operator

Good afternoon. My name is Jonathan, and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences conference call for the third quarter ended -- fourth quarter ended December 31, 2021. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to introduce your host for today's program, Susan Pietropaolo from -- please go ahead.

Susan M. Pietropaolo - SMP Communications, Inc. - Principal

Thank you, Jonathan. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the year ended, fourth quarter ended December 31, 2021. Earlier today, Aptose issued a press release related to these financial results. The news release as well as related SEC filings are accessible on Aptose's website.

Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO; Dr. Joti Marango, Senior Vice President, Chief Financial Officer and Chief Business Officer; and Dr. Rafael Bejar, Senior Vice President, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot